According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, and the effects are impressive. A 2022 study found that people who received weekly semaglutide injections lost an average of about 15 pounds after three months.

Ozempic and other drugs like it have been threatening the more traditional weight loss industry since they premiered — and it appears that Weight Watchers is the first to get the hatchet. In a note to investors,

Once boasting up to five million subscribers and backed by the likes of Oprah Winfrey, the company is now trying to shed debt and restructure